CPT code 0259U: eGFR assay, serum NMR and cystatin C2026 Medicare lab fee · Clinical Laboratory Fee Schedule

This serum assay combines nuclear magnetic resonance measurements and cystatin C with demographic data to produce a quantitative estimated glomerular filtration rate for chronic kidney disease assessment.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide

Medicare pays $52.71 for 0259U under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$52.71

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2022
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 8 sections
  1. Medicare lab fee
  2. What 0259U covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Related codes
  7. Billing questions
  8. Sources

What 0259U covers

This proprietary laboratory analysis uses nuclear magnetic resonance spectroscopy to measure serum myo-inositol, valine, and creatinine. An algorithm combines those results with cystatin C measured by immunoassay and demographic data to calculate a quantitative estimated glomerular filtration rate. The assay reports the integrated result as eGFR. It supports nephrology assessment of chronic kidney disease and kidney filtration. The reported result is an estimate rather than a direct measurement of filtration.

Report 0259U for the integrated assay. Medicare pays it only through the CLFS, at one national amount per code across all localities, without an office or facility difference. The 2026 national CLFS amount is $52.71 and has remained unchanged since 2022. The code has no physician fee schedule payment.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 0259U

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 0259U. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Not on the physician fee schedule

The physician fee schedule doesn’t list 0259U: Medicare pays the test only from the CLFS.

0259U on the lab fee schedule since 2021

0259U · CLFS 2026 Q4 (current)

$52.71

Unchanged since Jan 1, 2022

Amount in each year’s latest CLFS release · bars start at $0

Every change on file

  1. Jan 1, 2022 · CLFS 2022 Q1MAC-priced → $52.71

21 quarterly CLFS releases on file, first CLFS 2021 Q4. A code missing from a quarter wasn’t on that release.

0259U compared with similar tests

82565CreatinineBlood specimen$5.12
82565 reports a creatinine measurement. Use 0259U for the integrated serum NMR and cystatin C assay that calculates estimated GFR.
82610Cystatin C$18.52
82610 reports cystatin C measurement alone. In 0259U, cystatin C is combined with NMR analytes and demographic data to calculate estimated GFR.
80069Renal panelKidney-focused chemistry panel$8.68
80069 is a renal function chemistry panel. 0259U is a distinct integrated assay using NMR measurements and cystatin C to estimate GFR.
82575Creatinine clearanceTimed urine and serum$9.46
82575 reports creatinine clearance assessment. 0259U calculates estimated GFR using the described serum NMR and cystatin C algorithm.

0259U billing questions

How is this different from a creatinine-based eGFR assessment?

This assay uses NMR measurements of myo-inositol, valine, and creatinine, then combines them with immunoassay cystatin C and demographic data. A creatinine test such as 82565 measures creatinine rather than this integrated assay.

What specimen and method does 0259U describe?

The assay uses serum and nuclear magnetic resonance spectroscopy for myo-inositol, valine, and creatinine. Cystatin C is measured by immunoassay for the algorithm.

Does 0259U include a cystatin C measurement?

Yes. Cystatin C measured by immunoassay is one of the inputs combined with the NMR results and demographic data to calculate estimated GFR.

What result does 0259U report?

It reports a quantitative estimated glomerular filtration rate calculated from the NMR measurements, cystatin C, and demographic data.

How does Medicare pay 0259U?

Medicare pays the code through the CLFS at one national amount that applies across localities, with no office or facility difference. There is no physician fee schedule payment for the code.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 0259UPUF_CLFS_CY2026_Q4V1.csv, line 229 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 0259U?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 0259U and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist